Q2 2026

PeriodNumber of sell-side
analysts participation
Adj. EBITDA consensus average
Q2-20267Average: EUR 121 million
Range: EUR 110 – 142 million

* Data as of 1st July 2026

 

Disclaimer

The consensus figures are based on estimates, forecasts and predictions made by third party financial analysts and can only be seen as a consensus view on Aperam’s results from an outside perspective. Aperam does not accept any responsibility for the quality or accuracy of forecasts or estimates. This web page may contain forward-looking statements based on current assumptions and forecasts made by Aperam or third parties. Various known and unknown risks, uncertainties and other factors could lead to material differences between Aperam’s actual future results, financial situation, development or performance, and the estimates given here. These factors include those discussed in Aperam’s periodic reports available on www.aperam.com, section Investors & Shareholders.1

All earnings reports and related documents are available for download